Nasdaq: $30.02 (+4.13) | AIM: £4.27 (+0.57)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Discovery and Early Development of HMPL-504 (savolitinib)